Panagiotis Giannopoulos

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

Jesse J. Swen, Cathelijne H. van der Wouden, Lisanne E. N. Manson et al. · The Lancet · 2023 · 462 citations · Full text

Drug Safety, Adverse Drug Reactions, Pharmacoepidemiology +9

ALCAM and VCAM-1 as urine biomarkers of activity and long-term renal outcome in systemic lupus erythematosus

Ioannis Parodis, Sirisha Gokaraju, Agneta Zickert et al. · Lara D. Veeken · 2019 · 61 citations · Full text

Clinical implementation of preemptive pharmacogenomics in psychiatry

Kariofyllis Karamperis, Margarita-Ioanna Koufaki, Evangelia Eirini Tsermpini et al. · EBioMedicine · 2024 · 49 citations · Full text

The discovery of new potent non-peptide Angiotensin II AT1 receptor blockers: A concise synthesis, molecular docking studies and biological evaluation of N-substituted 5-butylimidazole derivatives

George Agelis, Amalia Resvani, Serdar Durdağı et al. · European Journal of Medicinal Chemistry · 2012 · 40 citations · Full text

Molecular Docking Studies, Medicinal Chemistry, Concise Synthesis +11

Advanced Trauma Life Support certified physicians in a non trauma system setting: Is it enough?

Panagiotis Drimousis, Dimitrios Theodorou, Konstantinos Toutouzas et al. · Resuscitation · 2010 · 34 citations

Trauma Resuscitation, Trauma Center Care, Trauma Care +9